Overview

Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss

Status:
Completed

Trial end date:
2018-10-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether ancrod is effective and safe in the treatment of sudden sensorineural hearing loss (SSHL).

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Nordmark Arzneimittel GmbH & Co. KG

Collaborators:

ClinSupport GmbH
LCR Leading Clinical Research s.r.o.
MWI Medizinisches Wirtschaftsinstitut GmbH
ProjectPharm s.r.o.
X-act Cologne Clinical Research GmbH

Treatments:

Ancrod
Pharmaceutical Solutions